Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Monographs in Clinical Cytology|September 28, 2020
Imaging of Pancreatic TumorsBrian Morse, Jason KlapmanAbdominal Radiology (New York)|June 20, 2024
Percutaneous liver-directed therapies of intrahepatic cholangiocarcinomaBrian Morse, Melissa McGettigan, Bela KisThe American Journal of Medicine|May 20, 2014
Autoimmune pancreatitis: updated concepts of a challenging diagnosisBrian Morse, Barbara Centeno, Shivakumar VigneshCurrent Oncology (Toronto, Ont.)|February 24, 2022
Efficacy of Capecitabine and Temozolomide in Small Bowel (Midgut) Neuroendocrine TumorsTaymeyah Al-Toubah, Brian Morse, Jonathan StrosbergThe Oncologist|August 29, 2019
Capecitabine and Temozolomide in Advanced Lung Neuroendocrine NeoplasmsTaymeyah Al-Toubah, Brian Morse, Jonathan StrosbergCurrent Treatment Options in Oncology|July 31, 2020
Anatomic and Functional Imaging of Neuroendocrine TumorsBrian Morse, Taymeyah Al-Toubah, Jaime Montilla-SolerThe Oncologist|November 23, 2020
Efficacy of FOLFOX in Patients with Aggressive Pancreatic Neuroendocrine Tumors After Prior Capecitabine/TemozolomideTaymeyah Al-Toubah, Brian Morse, Eleonora Pelle, et al.Journal of the National Comprehensive Cancer Network : JNCCN|December 12, 2022
Belzutifan in a Patient With VHL-Associated Metastatic Pancreatic Neuroendocrine TumorEleonora Pelle, Taymeyah Al-Toubah, Brian Morse, et al.Abdominal Radiology (New York)|September 10, 2018
Pearls and pitfalls of response evaluation criteria in solid tumors (RECIST) v1.1 non-target lesion assessmentBrian Morse, Daniel Jeong, Gary Ihnat, et al.Pancreas|September 14, 2017
Magnetic Resonance Imaging of Neuroendocrine Tumor Hepatic Metastases: Does Hepatobiliary Phase Imaging Improve Lesion Conspicuity and Interobserver Agreement of Lesion Measurements?Brian Morse, Daniel Jeong, Kerry Thomas, et al.Pageof 3